Diabetes, metformin and glucose lowering therapies after myocardial infarction: Insights from the SWEDEHEART registry
{{output}}
Objective: To explore real-life use of glucose lowering drugs and prognosis after acute myocardial infarction (AMI) with a special focus on metformin. Methods: ... ...
